Expand/collapse navigation
Home
About Us
EQA/PT Programmes
Trial Schedules
New Participant Information
EQA Programme Development Pipeline
Flow Cytometry Programmes
CD34+ Stem Cell Enumeration (Accredited)
Immune Monitoring (Accredited)
Leukaemia Diagnostic Interpretation (Part 2) (Accredited)
Leukaemia Immunophenotyping (Part 1) (Accredited)
Low Level Leucocyte Enumeration (Accredited)
Measurable Residual Disease for ALL by Flow Cytometry (Accredited)
Paroxysmal Nocturnal Haemoglobinuria (Accredited)
Cerebrospinal Fluid (CSF) Immunophenotyping (Pilot - Not Accredited)
Haematological Malignancy Bone Marrow Aspirate Assessment (Pilot - Not Accredited)
Measurable Residual Disease for AML by Flow Cytometry (Pilot - Not Accredited)
Measurable Residual Disease for CLL by Flow Cytometry (Pilot - Not Accredited)
Measurable Residual Disease for Plasma Cell Myeloma by Flow Cytometry (Pilot - Not Accredited)
*NEW Competency Assessment and Instrument Validation Panel for Immune Monitoring
Molecular Haemato-Oncology Programmes
*BCR::ABL1 and AML Translocation Identification (Accredited)
BCR::ABL1 Kinase Domain Variant (Mutation) Status
BCR::ABL1 Major Quantification (Accredited)
BRAF p.Val600Glu (V600E) Mutation Status for Hairy Cell Leukaemia (Accredited)
*FLT3 Mutation Status (Accredited)
IG/TCR Clonality Status (Accredited)
JAK2 p.Val617Phe (V617F) Mutation Status (Accredited)
KIT p.Asp816Val (D816V) Mutation Status for Mast Cell Disease (Accredited)
NPM1 Mutation Status (Accredited)
Paediatric Acute Leukaemia Translocations (Accredited)
Post-Stem Cell Transplant Chimerism Monitoring (Accredited)
*Acute Myeloid Leukaemia and Myelodysplastic Syndrome Gene Panels (Pilot - Not Accredited)
BCR::ABL1 Minor Quantification (Pilot - Not Accredited)
Lymphoid Gene Panels (Pilot - Not Accredited)
Lymphoplasmacytic Lymphoma/Waldenström Macroglobulinaemia (Pilot - Not Accredited)
*Myeloproliferative Neoplasm Diagnostic Testing (Pilot - Not Accredited)
*NEW - Measurable Residual Disease for AML by Molecular Methods (Pilot - Not Accredited)
News/Events
Education and Events
UK NEQAS LI Scientific Meeting 2015
UK NEQAS LI Posters
UK NEQAS LI Scientific Meeting 2013
Educational Videos/User Guides
User Guides
Lectures
2022/2023 Programme Flyers
Contact us
Home
About Us
EQA/PT Programmes
News/Events
Contact us
Sitemap
Home
About Us
EQA/PT Programmes
Trial Schedules
New Participant Information
EQA Programme Development Pipeline
Flow Cytometry Programmes
CD34+ Stem Cell Enumeration (Accredited)
Immune Monitoring (Accredited)
Leukaemia Diagnostic Interpretation (Part 2) (Accredited)
Leukaemia Immunophenotyping (Part 1) (Accredited)
Low Level Leucocyte Enumeration (Accredited)
Measurable Residual Disease for ALL by Flow Cytometry (Accredited)
Paroxysmal Nocturnal Haemoglobinuria (Accredited)
Cerebrospinal Fluid (CSF) Immunophenotyping (Pilot - Not Accredited)
Haematological Malignancy Bone Marrow Aspirate Assessment (Pilot - Not Accredited)
Measurable Residual Disease for AML by Flow Cytometry (Pilot - Not Accredited)
Measurable Residual Disease for CLL by Flow Cytometry (Pilot - Not Accredited)
Measurable Residual Disease for Plasma Cell Myeloma by Flow Cytometry (Pilot - Not Accredited)
*NEW Competency Assessment and Instrument Validation Panel for Immune Monitoring
Molecular Haemato-Oncology Programmes
*BCR::ABL1 and AML Translocation Identification (Accredited)
BCR::ABL1 Kinase Domain Variant (Mutation) Status
BCR::ABL1 Major Quantification (Accredited)
BRAF p.Val600Glu (V600E) Mutation Status for Hairy Cell Leukaemia (Accredited)
*FLT3 Mutation Status (Accredited)
IG/TCR Clonality Status (Accredited)
JAK2 p.Val617Phe (V617F) Mutation Status (Accredited)
KIT p.Asp816Val (D816V) Mutation Status for Mast Cell Disease (Accredited)
NPM1 Mutation Status (Accredited)
Paediatric Acute Leukaemia Translocations (Accredited)
Post-Stem Cell Transplant Chimerism Monitoring (Accredited)
*Acute Myeloid Leukaemia and Myelodysplastic Syndrome Gene Panels (Pilot - Not Accredited)
BCR::ABL1 Minor Quantification (Pilot - Not Accredited)
Lymphoid Gene Panels (Pilot - Not Accredited)
Lymphoplasmacytic Lymphoma/Waldenström Macroglobulinaemia (Pilot - Not Accredited)
*Myeloproliferative Neoplasm Diagnostic Testing (Pilot - Not Accredited)
*NEW - Measurable Residual Disease for AML by Molecular Methods (Pilot - Not Accredited)
News/Events
Education and Events
UK NEQAS LI Scientific Meeting 2015
UK NEQAS LI Posters
UK NEQAS LI Scientific Meeting 2013
Educational Videos/User Guides
User Guides
Lectures
2022/2023 Programme Flyers
Contact us
Organisations
Publications
Resources
Non-UK Distributors
UK NEQAS Centres